​New Look at Asset Allocation for Retirees

MoneyShow |


When suggesting a sample allocation for a 66-year old retiree, I think it is wise to tread a different path from what Wall Street tells you when it comes to stock allocation, suggests Tony Daltorio, editor of The Growth Stock Advisor.

When I began my career in the investment industry, the general “rule” was that the allocation to stocks should be 100% minus your age. Then it became 120% minus your age.

I think today it's to be 100% invested in stocks even 10 years after death. Just kidding, of course. I would tell people the smart move was to drastically lower their stock allocation in the 2-3 years before retirement and the 2-3 years after retirement.

That way your capital is preserved at the most crucial time in your investing lifecycle. For example, if the stock allocation in a portfolio was at 60%, I would recommend a steep drop to around only 20%.

Consider that a 25% drawdown would almost certainly end your dreams of a nice retirement. In that case, your $100,000 portfolio would suddenly be worth only $75,000. Then you would need to earn a 33% return (which likely would take years) just to get back to even.

Keep in mind too that between October 2007 and March 2009, the S&P 500 index lost 55% of its value.

But after that crucial period surrounding your planned retirement date passes, you must raise the stock allocation back to normal levels. You'll need the growth to offset those rising costs of healthcare and other necessities.

Let me work through one example for you. Please keep in mind though that since every one of you has unique circumstances, you will need to consult with a licensed financial professional to work out a specific plan for you and your family. I'm just providing a basic example here.

Let's assume for the example that this person has already gotten through that period surrounding their retirement date that I spoke about and is 66 years old. What should his or her portfolio look like?

I will use only ETFs in this example, not individual securities. I will also try to stick to exchange traded products (ETFs and ETNs) that are available for no fee (commissions) at discount brokers like my former employer, Charles Schwab, and others.

Again, I repeat, this is only an example. Don't run out and buy these ETFs before doing your own due diligence. With no end in sight to inflation in the healthcare sector, I would be aggressive and put 65% into stock funds, while including some global exposure.

Even though I'm no fan of index funds, I have no problem with our example investor putting 5% or so into an S&P 500 index fund. Then, here is a possible allocation for the person I described:

I would put about 25% into U.S. funds that emphasize dividends such as the Wisdomtree U.S. Quality Dividend Growth Fund (DGRW), which has risen 11.5% so far in 2017.

Next, I would put 20% into international stocks.



But do NOT put this money into index funds, which perform poorly internationally.

The reason is simple – in emerging markets, for example, 77% of all stocks are excluded from the indexes. So, I would opt for ETFs such as the Wisdomtree Global ex-U.S. Quality Dividend Growth Fund (DNL) and the Wisdomtree Emerging Markets Quality Dividend Growth Fund (DGRE). These ETFs are up 16.7% and 14.8% respectively year-to-date.

Finally, on the stock side, I would consider putting 15% into specialty funds that emphasize growth such as the John Hancock Multifactor Technology ETF (JMHT) and the John Hancock Multifactor Health Care ETF (JHMH). These funds have risen 16.4% and 17.0% respectively year-to-date.

I would put only 20% into fixed income funds at this time because of the high current valuations of bonds around the world. I would include government, corporate and emerging market fixed income securities, but steer clear of high-yield bonds.

Some possibilities here include: SPDR Bloomberg Barclays Long-Term Treasury ETF (TLO), Pimco Investment Grade Corporate Bond Index ETF (CORP) and the PowerShares Emerging Market Sovereign Debt Portfolio (PCY). The performance of these funds year-to-date are: up 5.8%, up 4.0% and up 6.3% respectively.

Finally, I would put 15% into alternative assets including real estate and precious metals.

In the real estate sector, I would look for a fund that offers global exposure.

One such ETF is the SPDR Dow Jones Global Real Estate ETF (RWO). Its portfolio contains over 200 of the world's top real estate firms and REITs, with roughly 60% of the portfolio in the U.S. This fund is up 3.2% year-to-date.

A fund for precious metals is the ETFs Physical Precious Metals Basket Shares (GLTR). It owns physical bullion in all four of the major precious metals in the following approximate proportion: Gold –58.31%, Silver –27.93%, Platinum –8.00%, Palladium –5.76%. GLTR has risen 7.3% year-to-date.

Tony Daltorio is editor of Investors Alley Premium Digest.

Subscribe to The Growth Stock Advisor here…

About MoneyShow.com: Founded in 1981, MoneyShow is a privately held financial media company headquartered in Sarasota, Florida. As a global network of investing and trading education, MoneyShow presents an extensive agenda of live and online events that attract over 75,000 investors, traders and financial advisors around the world.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Companies

Symbol Name Price Change % Volume
dnl WisdomTree Global ex-US Quality Dividend Growth Fund
DGRE WisdomTree Emerging Markets Quality Dividend Growth Fund 25.91 0.22 0.86 2,332 Trade
JHMT John Hancock Multifactor Technology 40.97 0.18 0.43 16,408
JHMH John Hancock Multifactor Healthcare 31.00 0.20 0.65 1,055
DGRW WisdomTree U.S. Quality Dividend Growth Fund 41.05 0.26 0.64 182,592 Trade

Comments

Emerging Growth

Invictus MD Strategies Corp

Invictus MD Strategies Corp is engaged in the investment, acquisition and development of synergistic businesses in an effort to increase and sustain growth and value.

Private Markets

The Green Organic Dutchman

The Green Organic Dutchman Ltd. ("TGOD") produces farm grown, organic cannabis for medical use. The company grows its high quality organic cannabis in small batches using craft growing, all natural…

Voleo

Voleo is a free download that allows you to form investment clubs with your friends, family, colleagues, classmates, teammates…basically anyone you know and trust. Invest and manage a stock portfolio…